» Articles » PMID: 24586911

HIV-1 Transmission Patterns in Antiretroviral Therapy-naïve, HIV-infected North Americans Based on Phylogenetic Analysis by Population Level and Ultra-deep DNA Sequencing

Overview
Journal PLoS One
Date 2014 Mar 4
PMID 24586911
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Factors that contribute to the transmission of human immunodeficiency virus type 1 (HIV-1), especially drug-resistant HIV-1 variants remain a significant public health concern. In-depth phylogenetic analyses of viral sequences obtained in the screening phase from antiretroviral-naïve HIV-infected patients seeking enrollment in EPZ108859, a large open-label study in the USA, Canada and Puerto Rico (ClinicalTrials.gov NCT00440947) were examined for insights into the roles of drug resistance and epidemiological factors that could impact disease dissemination. Viral transmission clusters (VTCs) were initially predicted from a phylogenetic analysis of population level HIV-1 pol sequences obtained from 690 antiretroviral-naïve subjects in 2007. Subsequently, the predicted VTCs were tested for robustness by ultra deep sequencing (UDS) using pyrosequencing technology and further phylogenetic analyses. The demographic characteristics of clustered and non-clustered subjects were then compared. From 690 subjects, 69 were assigned to 1 of 30 VTCs, each containing 2 to 5 subjects. Race composition of VTCs were significantly more likely to be white (72% vs. 60%; p = 0.04). VTCs had fewer reverse transcriptase and major PI resistance mutations (9% vs. 24%; p = 0.002) than non-clustered sequences. Both men-who-have-sex-with-men (MSM) (68% vs. 48%; p = 0.001) and Canadians (29% vs. 14%; p = 0.03) were significantly more frequent in VTCs than non-clustered sequences. Of the 515 subjects who initiated antiretroviral therapy, 33 experienced confirmed virologic failure through 144 weeks while only 3/33 were from VTCs. Fewer VTCs subjects (as compared to those with non-clustering virus) had HIV-1 with resistance-associated mutations or experienced virologic failure during the course of the study. Our analysis shows specific geographical and drug resistance trends that correlate well with transmission clusters defined by HIV sequences of similarity. Furthermore, our study demonstrates the utility of molecular and epidemiological analysis of VTCs for identifying population-specific risks associated with HIV-1 transmission and developing effective local healthcare strategies.

Citing Articles

HIV-1 molecular transmission clusters in nine European countries and Canada: association with demographic and clinical factors.

Paraskevis D, Beloukas A, Stasinos K, Pantazis N, de Mendoza C, Bannert N BMC Med. 2019; 17(1):4.

PMID: 30616632 PMC: 6323837. DOI: 10.1186/s12916-018-1241-1.


Leveraging Phylogenetics to Understand HIV Transmission and Partner Notification Networks.

Pasquale D, Doherty I, Sampson L, Hue S, Leone P, Sebastian J J Acquir Immune Defic Syndr. 2018; 78(4):367-375.

PMID: 29940601 PMC: 6058319. DOI: 10.1097/QAI.0000000000001695.

References
1.
Callegaro A, Svicher V, Alteri C, Lo Presti A, Valenti D, Goglio A . Epidemiological network analysis in HIV-1 B infected patients diagnosed in Italy between 2000 and 2008. Infect Genet Evol. 2011; 11(3):624-32. DOI: 10.1016/j.meegid.2011.01.019. View

2.
Ahumada-Ruiz S, Flores-Figueroa D, Toala-Gonzalez I, Thomson M . Analysis of HIV-1 pol sequences from Panama: identification of phylogenetic clusters within subtype B and detection of antiretroviral drug resistance mutations. Infect Genet Evol. 2009; 9(5):933-40. DOI: 10.1016/j.meegid.2009.06.013. View

3.
Little S, Frost S, Wong J, Smith D, Kosakovsky Pond S, Ignacio C . Persistence of transmitted drug resistance among subjects with primary human immunodeficiency virus infection. J Virol. 2008; 82(11):5510-8. PMC: 2395184. DOI: 10.1128/JVI.02579-07. View

4.
Lai A, Violin M, Ebranati E, Franzetti M, Micheli V, Gismondo M . Transmission of resistant HIV type 1 variants and epidemiological chains in Italian newly diagnosed individuals. AIDS Res Hum Retroviruses. 2011; 28(8):857-65. PMC: 3399563. DOI: 10.1089/aid.2011.0245. View

5.
Castro E, Khonkarly M, Ciuffreda D, Burgisser P, Cavassini M, Yerly S . HIV-1 drug resistance transmission networks in southwest Switzerland. AIDS Res Hum Retroviruses. 2010; 26(11):1233-8. DOI: 10.1089/aid.2010.0083. View